Cardiac pumping ability in rats with experimental renal and genetic hypertension.
In two experimental models of established hypertension in the rat (two kidney, one clip renal and genetic hypertension), the maximum by which stroke volume and cardiac output could be increased during an acute preload stress was significantly reduced despite the concomitant development of left ventricular hypertrophy. Reversal of cardiac hypertrophy by prolonged treatment with methyldopa (range 3 to 6 weeks) during the established phase of spontaneous hypertension normalized arterial blood pressure and improved ventricular pumping ability. The improved performance was in part due to reduced impedance to ventricular ejection because it did not persist when peripheral resistance was increased by an acute administration of phenylephrine hydrochloride. Thus, hemodynamic as well as structural factors contribute to alterations in cardiac function during the chronic established phase of arterial hypertension.
D000818:Animals; D001769:Blood; D001794:Blood Pressure; D001835:Body Weight; D002302:Cardiac Output; D006321:Heart / Q000033:anatomy & histology; D006339:Heart Rate; D006439:Hemodynamics / Q000187:drug effects; D006973:Hypertension / Q000235:genetics*; D006977:Hypertension, Renal / Q000503:physiopathology*; D007263:Infusions, Parenteral; D008750:Methyldopa / Q000494:pharmacology; D009929:Organ Size; D051381:Rats; D013312:Stress, Physiological; D013318:Stroke Volume
D008750:Methyldopa